Safety demonstrated for stem cell delivery technology in HF

A study exploring use of a system allowing standardization of the delivery of autologous mesenchymal stromal cells in heart failure has met its primary safety and efficacy end points. Topics: Heart Failure (HF)
Source: ESC News and Press - Category: Cardiology Source Type: news